drugset / Trial / NCT02102113

Probing the Cannabinoid System in Individuals With a Family History of Psychosis

NCT02102113 ↗

Phase 0 Active not recruiting 21 enrolled Yale University
RandomizedCrossoverDouble-blindOther

Summary

The overall purpose of this study is to determine whether a family history of psychosis is associated with an altered cannabinoid system. This will be tested by studying individuals with and without a family history of psychosis and comparing their responses to delta 9-tetrahydrocannabinol (THC), a probe of the cannabinoid system. We hypothesize, that compared to controls with no family history of psychoses, individuals with a family history of psychoses will have an altered response to THC.

Timeline

Start
2014-01
Primary completion
2026-06
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject THC Unknown 0.01 mg/kg —
Subject THC Unknown 0.018 mg/kg —